Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001140361-17-044957)

Filing Details

Accession Number:: 0001140361-17-044957
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-12-04 20:26:14
Reporting Period:: 2017-11-30

Accepted Time:: 2017-12-04 20:26:14
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1048477	Biomarin Pharmaceutical Inc	BMRN	Pharmaceutical Preparations (2834)	680397820

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1380710	Eric George Davis	C/O Biomarin Pharmaceutical Inc. 770 Lindaro St. San Rafael CA 94901	Evp, General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2017-11-30	1,200	$85.64	82,942	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

All shares sold at the same price.
Amount of securities beneficially owned has been updated from the reporting person's prior report to: a) include 804 shares reported in the Form 4 Amendment filed with the S.E.C. on 10/13/2017; and b) exclude 243 shares inadvertently included in prior reports based on a reconciliation with the Company's records.